Journal of the American Society of Hypertension
Volume 3, Issue 5 , Pages 295-305 , September 2009

Potentiation of vascular oxidative stress and nitric oxide-mediated endothelial dysfunction by high-fat diet in a mouse model of estrogen deficiency and hyperandrogenemia

  • Danesh Javeshghani, PhD

      Affiliations

    • Vascular and Hypertension Research Unit, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    • Reproduction Research Laboratory, Clinical Research Institute of Montreal, Montreal, University of Montreal, Quebec, Canada
    • Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
    • ,
  • Ernesto L. Schiffrin, MD, PhD

      Affiliations

    • Vascular and Hypertension Research Unit, Lady Davis Institute for Medical Research, Sir Mortimer B. Davis-Jewish General Hospital, McGill University, Montreal, Quebec, Canada
    • ,
  • M. Ram Sairam, PhD

      Affiliations

    • Reproduction Research Laboratory, Clinical Research Institute of Montreal, Montreal, University of Montreal, Quebec, Canada
    • ,
  • Rhian M. Touyz, MD, PhD

      Affiliations

    • Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada
    • Corresponding Author InformationCorresponding author: Rhian M. Touyz, MD, PhD, Kidney Research Centre, OHRI/University of Ottawa, 451 Smyth Road, Room 1333A, Ottawa, ON K1H 8M5, Canada. Tel: 613-562-5800 (ext. 8241); fax: 613-562-5487.

Received 28 April 2009 ,Accepted 29 July 2009.

References 

  1. Davy KP, Hall JE. Obesity and hypertension: two epidemics or one?. Am J Physiol Regul Integr Comp Physiol. 2004;286:R803–R813
  2. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol. 2006;26:968–976
  3. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87:840–844
  4. De Vriese AS, Verbeuren TJ, van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol. 2000;130:963–974
  5. Serock MR, Wells AK, Khalil RA. Modulators of vascular sex hormone receptors and their effects in estrogen-deficiency states associated with menopause. Recent Patents Cardiovasc Drug Discov. 2008;3:165–186
  6. Javeshghani D, Touyz RM, Sairam MR, Virdis A, Neves MF, Schiffrin EL. Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension. Hypertension. 2003;42:761–767
  7. Reckelhoff JF, Fortepiani LA. Novel mechanisms responsible for postmenopausal hypertension. Hypertension. 2004;43:918–923
  8. Shehata M, Kamel MA. Protective effect of antioxidant adjuvant treatment with hormone replacement therapy against cardiovascular diseases in ovariectomized rats. Endocr Regul. 2008;42:69–75
  9. Lopez-Ruiz A, Sartori-Valinotti J, Yanes LL, Iliescu R, Reckelhoff JF. Sex differences in control of blood pressure: role of oxidative stress in hypertension in females. Am J Physiol Heart Circ Physiol. 2008;295:H466–H468
  10. Lam KK, Lee YM, Hsiao G, Chen SY, Yen MH. Estrogen therapy replenishes vascular tetrahydrobiopterin and reduces oxidative stress in ovariectomized rats. Menopause. 2006;13:294–302
  11. Liang W, Tan CY, Ang L, Sallam N, Granville DJ, Wright JM, et al. Ramipril improves oxidative stress-related vascular endothelial dysfunction in db/db mice. J Physiol Sci. 2008;58:405–411
  12. Wang MY, Grayburn P, Chen S, Ravazzola M, Orci L, Unger RH. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc Natl Acad Sci U S A. 2008;105:6139–6144
  13. Knudson JD, Dincer UD, Dick GM, Shibata H, Akahane R, Saito M, et al. Leptin resistance extends to the coronary vasculature in prediabetic dogs and provides a protective adaptation against endothelial dysfunction. Am J Physiol Heart Circ Physiol. 2005;289:H1038–H1046
  14. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A. 1998;95:6965–6970
  15. Sairam MR, Danilovich N, Lussier-Cacan S. The FORKO mouse as a genetic model for exploring estrogen replacement therapy. J Reprod Med. 2002;47:412–418
  16. Danilovich N, Babu PS, Xing W, Gerdes M, Krishnamurthy H, Sairam MR. Estrogen deficiency, obesity, and skeletal abnormalities in follicle-stimulating hormone receptor knockout (FORKO) female mice. Endocrinology. 2000;141:4295–4308
  17. Misso ML, Hewitt KN, Boon WC, Murata Y, Jones ME, Simpson ER. Cholesterol feeding prevents adiposity in the obese female aromatase knockout (ArKO) mouse. Horm Metab Res. 2005;37:26–31
  18. Jones ME, McInnes KJ, Boon WC, Simpson ER. Estrogen and adiposity–utilizing models of aromatase deficiency to explore the relationship. J Steroid Biochem Mol Biol. 2007;106:3–7
  19. Zhang H, Chen X, Aravindakshan J, Sairam MR. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance. Endocrinology. 2007;148:5667–5669
  20. Marcoux C, Tremblay M, Nakajima K, Davignon J, Cohn JS. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients. J Lipid Res. 1999;40:636–647
  21. Rayalam S, Della-Fera MA, Baile CA. Phytochemicals and regulation of the adipocyte life cycle. J Nutr Biochem. 2008;19:717–726
  22. Yi KW, Shin JH, Seo HS, Lee JK, Oh MJ, Kim T, et al. Role of estrogen receptor-alpha and -beta in regulating leptin expression in 3T3-L1 adipocytes. Obesity (Silver Spring). 2008;16:2393–2399
  23. Muraki K, Okuya S, Tanizawa Y. Estrogen receptor alpha regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytes. Endocr J. 2006;53:841–851
  24. Blouin K, Nadeau M, Mailloux J, Daris M, Lebel S, Luu-The V, et al. Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis. Am J Physiol Endocrinol Metab. 2009;296:E244–E255
  25. Wake DJ, Strand M, Rask E, Westerbacka J, Livingstone DE, Soderberg S, et al. Intra-adipose sex steroid metabolism and body fat distribution in idiopathic human obesity. Clin Endocrinol (Oxf). 2007;66:440–446
  26. Gooren L. Visceral obesity, the metabolic syndrome, androgens and estrogens. Aging Male. 2006;9:75–79
  27. Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril. 2006;85:1319–1340
  28. Schreyer SA, Vick C, Lystig TC, Mystkowski P, LeBoeuf RC. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab. 2002;282:E207–E214
  29. Albers JJ, Pitman W, Wolfbauer G, Cheung MC, Kennedy H, Tu AY, et al. Relationship between phospholipid transfer protein activity and HDL level and size among inbred mouse strains. J Lipid Res. 1999;40:295–301
  30. Shi Q, Vandeberg JF, Jett C, Rice K, Leland MM, Talley L, et al. Arterial endothelial dysfunction in baboons fed a high-cholesterol, high-fat diet. Am J Clin Nutr. 2005;82:751–759
  31. Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism. 2000;49:22–31
  32. Aoki R, Ikarugi H, Naemura A, Ijiri Y, Yamashita T, Yamamoto J. Endothelial dysfunction precedes atherosclerotic lesions and platelet activation in high-fat diet-induced prothrombotic state. Thromb Res. 2006;117:529–535
  33. Miller VM, Duckles SP. Vascular actions of estrogens: functional implications. Pharmacol Rev. 2008;60:210–241
  34. Vouyouka AG, Kent KC. Arterial vascular disease in women. J Vasc Surg. 2007;46:1295–1302
  35. Davies RS, Vohra RK, Bradbury AW, Adam DJ. The impact of hormone replacement therapy on the pathophysiology of peripheral arterial disease. Eur J Vasc Endovasc Surg. 2007;34:569–575
  36. Al Suwaidi J, Higano ST, Holmes DR, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001;37:1523–1528
  37. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Chayama K, Oshima T. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension. Am J Hypertens. 2001;14:1038–1045
  38. Marchesi S, Vaudo G, Lupattelli G, Lombardini R, Roscini AR, Brozzetti M, et al. Fat distribution and endothelial function in normal-overweight menopausal women. J Clin Pharm Ther. 2007;32:477–482
  39. Martin JW, Briesmiester K, Bargardi A, Muzik O, Mosca L, Duvernoy CS. Weight changes and obesity predict impaired resting and endothelium-dependent myocardial blood flow in postmenopausal women. Clin Cardiol. 2005;28:13–18
  40. Bednarek-Tupikowska G, Tworowska-Bardzinska U, Tupikowski K. Effects of estrogen and estrogen-progesteron on serum nitric oxide metabolite concentrations in post-menopausal women. J Endocrinol Invest. 2008;31:877–881
  41. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol. 2004;122:339–352
  42. Forstermann U, Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708–1714
  43. Guzik TJ, West NE, Pillai R, Taggart DP, Channon KM. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension. 2002;39:1088–1094
  44. Noronha BT, Li JM, Wheatcroft SB, Shah AM, Kearney MT. Inducible nitric oxide synthase has divergent effects on vascular and metabolic function in obesity. Diabetes. 2005;54:1082–1089
  45. Moroe H, Honda H. Comparison of endothelial function in the carotid artery between normal and short-term hypercholesterolemic rabbits. Comp Biochem Physiol C Toxicol Pharmacol. 2006;144:197–203
  46. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care. 2008;31:S170–S180
  47. Ebrahimian T, Sairam MR, Schiffrin EL, Touyz RM. Cardiac hypertrophy is associated with altered thioredoxin and ASK-1 signaling in a mouse model of menopause. Am J Physiol Heart Circ Physiol. 2008;295:H1481–H1488
  48. Erdei N, Toth A, Pasztor ET, Papp Z, Edes I, Koller A, et al. High-fat diet-induced reduction in nitric oxide-dependent arteriolar dilation in rats: role of xanthine oxidase-derived superoxide anion. Am J Physiol Heart Circ Physiol. 2006;291:H2107–H2115
  49. Roberts CK, Barnard RJ, Sindhu RK, Jurczak M, Ehdaie A, Vaziri ND. A high-fat, refined-carbohydrate diet induces endothelial dysfunction and oxidant/antioxidant imbalance and depresses NOS protein expression. J Appl Physiol. 2005;98:203–210
  50. Merat S, Casanada F, Sutphin M, Palinski W, Reaven PD. Western-type diets induce insulin resistance and hyperinsulinemia in LDL receptor-deficient mice but do not increase aortic atherosclerosis compared with normoinsulinemic mice in which similar plasma cholesterol levels are achieved by a fructose-rich diet. Arterioscler Thromb Vasc Biol. 1999;19:1223–1230

 This study was supported by Grants Nos. 44018 (Dr. Touyz) and 13570 (Dr. Schiffrin) from the Canadian Institutes of Health Research. Drs. Touyz and Schiffrin are supported through Canada Research Chair/Canadian Foundation for Innovation awards. Dr. Javeshghani is the recipient of a Fellowship from the Heart and Stroke Foundation of Canada.

PII: S1933-1711(09)00100-4

doi: 10.1016/j.jash.2009.07.002

Journal of the American Society of Hypertension
Volume 3, Issue 5 , Pages 295-305 , September 2009

Article Tools

* Image Usage & Resolution